Abstract:In four patients with chronic pancreatitis from two hereditary pancreatitis (HP) families and 63 normal controls, five exons of cationic trypsinogen gene (PRSS1) were amplified by PCR and it's products were analyzed by sequencing, related clinical data were also collected. All the four patients were found mutations in the PRSS1 gene but their clinical feature is absolutely different. Six patients with diabetes mellitus were found in pedigree No. 1, it's members show pancreatitis symptom later, at about 29, the tumor markers (CA19-9, CA72-4) is obviously higher than the patients in pedigree No. 2, two patients with chronic pancreatitis in pedigree No. 2, show symptom earlier without diabetes mellitus, their clinical characterization are different too. The number of CD4+T cell/ CD8+T is very low in Ⅲ8, but Ⅲ7 is normal, and the level of anti-HBs of Ⅲ8 is variable in the course of pancreatitis, but the phenomenon was not found in Ⅲ7. In their PRSS1 gene two guanosine (G) to adenosine (A) mutations were found in PRSS1 exon 3 of pedigree No. 1, one was detected at 336 basyl, the other mutation occurs at 361 basyl. The results of the mutations were Lys →Lys and Ala →Thr. While thymine (T) to adenosine (A) and (guanosine) G→(adenosine) A mutation in PRSS1 exon 3 was detected in the other patient of pedigree No. 2 (Ⅲ8). One was 361 basyl, the other at 415 basyl. While c.415 T→A was not found in the proband of pedigree No. 2 PRSS1 gene (Ⅲ7). All of the mutations were heterozygous mutation, that is to say all of the trypsinogen were wild type and mutant type concomitance, the normal and abnormal pathway of active trypsinogen exist partially. At the same time, the mutations of SPINK1 were not observed. Compared with the documents and registration of NCBI, it can be concluded that PRSS1 gene had many kinds of mutations in hereditary pancreatitis, the heterozygous mutations (c.336 G→A, c.415 T→A) were the novel mutations and related with clinical phenotype. What's more, it's the first time that the multisite heterozygous mutations of PRSS1 gene were reported. The presence of the mutations in four patients with chronic pancreatitis, it's absence in their relatives and the strong evolutionary conservation of the mutation, all indicate that the trypsinogen mutation is associated with hereditary pancreatitis and for the first time raises the question whether a gain or a loss of trypsin function participates in the onset of Chinese pancreatitis.

S2512 Chronic Pancreatitis in a Young Female: A Rare Case of SPINK1 Mutation

Puestow surgery in a SPINK mutation chronic pancreatitis: a rare case report

A De Novo CaSR Missense Variant in Combination with Two Inherited Missense Variants in CFTR and SPINK1 Detected in a Patient with Chronic Pancreatitis

Heterozygous Spink1 c.194+2T>C mutation promotes chronic pancreatitis after acute attack in mice

Genetic Abnormalities in Pancreatitis: An Update on Diagnosis, Clinical Features, and Treatment

S2617 Hidden Behind Pancreatitis: Discovering a Solid Pseudopapillary Neoplasm in an Adolescent Male

The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant

SPINK1 mutations and risk of pancreatic cancer in a Chinese cohort

S2509 Catamenial Pancreatitis: A Rare Manifestation of Hereditary Pancreatitis

Case Report: Chronic pancreatitis in children as the cumulative effect of bilio-pancreatic abnormalities and genetic mutations

S2640 Hereditary Pancreatitis Associated With CFTR c.5T-TG12 Variant Mutation

Comprehensive Screening for PRSS1, SPINK1, CFTR, CTRC and CLDN2 Gene Mutations in Chinese Paediatric Patients with Idiopathic Chronic Pancreatitis: a Cohort Study.

Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis

Factors associated with prior acute pancreatitis episodes among patients with chronic pancreatitis

Genetic Factors Associated with Adverse Pregnancy Outcomes in Chronic Pancreatitis

SPINK1, PRSS1, CTRC, and CFTR Genotypes Influence Disease Onset and Clinical Outcomes in Chronic Pancreatitis.

Trypsin Activity Governs Increased Susceptibility to Pancreatitis in Mice Expressing Human PRSS1R122H

Multisite Heterozygous Mutations of PRSS1 Gene and Clinical Characterization of Patients with Hereditary Pancreatitis in the Chinese

Preclinical mouse model of a misfolded PNLIP variant develops chronic pancreatitis

Targeted Gene Next-Generation Sequencing in Chinese Children with Chronic Pancreatitis and Acute Recurrent Pancreatitis

Pancreas-directed AAV8 -hSPINK1 gene therapy safely and effectively protects against pancreatitis in mice